ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,768Medicare Part D Prescriptions Filled, Including Refills

Rank: 161 out of 761

$568K Total Retail Price of All Prescriptions

Rank: 82 out of 761

348 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 348 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

14% of this provider’s 348 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 5,714 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
LISINOPRIL 416 318 1 1
LEVOTHYROXINE SODIUM 334 252 2 3
HYDROCODONE-ACETAMINOPHEN 277 145 S3 3 5
SIMVASTATIN 262 196 4 2
OMEPRAZOLE 261 127 5 4
OXYCODONE HCL 230 76 S2 6 24
AMLODIPINE BESYLATE 191 157 7 6
HYDROCHLOROTHIAZIDE 174 140 8 11
METOPROLOL TARTRATE 170 146 9 14
GABAPENTIN 170 104 9 15
ATORVASTATIN CALCIUM 159 109 11 12
WARFARIN SODIUM 154 92 12 9
CITALOPRAM HBR 151 106 13 19
METFORMIN HCL 144 79 14 10
FUROSEMIDE 143 107 15 7
PRAVASTATIN SODIUM 123 96 16 20
METOPROLOL SUCCINATE 120 105 17 16
ATENOLOL 117 98 18 8
ADVAIR DISKUS 102 76 19 37
ZOLPIDEM TARTRATE 98 61 20 22
LOSARTAN POTASSIUM 95 90 21 13
TRAZODONE HCL 86 48 22 23
LOVASTATIN 85 64 23 17
LANTUS 81 45 24 41
HYDROMORPHONE HCL 80 0 S2 25 140
MORPHINE SULFATE ER 78 13 S2 26 38
SERTRALINE HCL 78 64 26 25
COMBIVENT 77 35 28 110
SPIRIVA 76 64 29 56
OXYCODONE HCL-ACETAMINOPHEN 75 24 S2 30 136
RANITIDINE HCL 70 23 31 52
CYCLOBENZAPRINE HCL 70 24 R 31 51
PREDNISONE 66 48 33 30
INSULIN SYRINGE 66 32 33 78
FLUTICASONE PROPIONATE 64 53 35 29
POTASSIUM CHLORIDE 64 48 35 18
CYMBALTA 63 19 37 53
FLUOXETINE HCL 62 26 38 31
ALENDRONATE SODIUM 61 42 39 21
PROAIR HFA 59 45 40 32
PANTOPRAZOLE SODIUM 57 47 41 40
TRAMADOL HCL 55 39 42 34
PROPRANOLOL HCL 53 13 43 100
ALLOPURINOL 53 51 43 28
OXYCONTIN 52 43 S2 45 114
METHADONE HCL 51 24 S2 46 75
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 3, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.